• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT Back to Search Results
Model Number AVSM10060
Medical Device Problem Codes Obstruction of Flow (2423); Material Deformation (2976)
Health Effect - Clinical Codes Pain (1994); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 03/18/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that fourteen days post stent placement procedure through cephalic arch, the stent was allegedly blocking off the basilic vein.It was further reported that the patient allegedly experienced pain and swelling in the arm and surgical intervention was performed.Reportedly the stent had to be removed and the procedure was completed using another device.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.D4 (expiration date: 10/2023).
 
Additional Manufacturer Narrative
H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the physical sample was returned for evaluation.The cut out covered stent was returned; but the condition after the mechanical cut out did not reflect the condition inside patient.The lumen of the covered stent was found open, and a verification of the condition inside patient was not possible.Images demonstrating the stent inside the vessel were not provided which leads to inconclusive evaluation result.Based on evaluation of the returned cut out covered stent the condition inside the vessel could not be verified which leads to inconclusive evaluation result.A definitive root cause could not be determined based upon the available information.Labeling review: in reviewing the relevant labeling for this product the potential issue was found addressed.The instruction for use closely describes holding and handling of the system throughout deployment, in particular the instruction for use state: 'maintain a stationary hold on the white stability sheath during covered stent deployment (.) hold the white stability sheath as close as possible to the introducer without touching the dark brown moving catheter of the distal catheter assembly.Maintain the remainder of the white stability sheath (segment between left and right hand on illustration) relaxed and avoid tension.' a covered stent diameter selection table describes the relationship between covered stent diameter and reference vessel or graft diameter.In regards to pta the instruction for use state: 'pre-dilate the stenosis with a pta balloon catheter of appropriate length and diameter for the lesion to be treated.', and 'post dilate the covered stent with an angioplasty balloon sized appropriately as to ensure complete wall apposition to the reference vessel.' under potential complication and adverse events the ifu state, but is not limited to: pain, thrombotic occlusion, restenosis of the target lesion requiring reintervention, insufficient covered stent expansion.H10: b2, d4 (expiration date: 10/2023), g3, h6 (patient, device) h11: h6 (method, result, conclusion) h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : see h10.
 
Event or Problem Description
It was reported that fourteen days post stent placement procedure through cephalic arch, the stent was allegedly blocking off the basilic vein.It was further reported that the patient allegedly experienced pain and swelling in the arm and surgical intervention was performed.Reportedly the stent had to be removed and the procedure was completed using another device.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVERA VASCULAR COVERED STENT
Common Device Name
VASCULAR COVERED STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key14194104
Report Number9681442-2022-00127
Device Sequence Number4378029
Product Code PFV
UDI-Device Identifier00801741106392
UDI-Public(01)00801741106392
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
P170042
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Reporter Type Manufacturer
Report Source Other,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberAVSM10060
Device Catalogue NumberAVSM10060
Device Lot NumberANFX0104
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/31/2022
Supplement Date Received by Manufacturer07/07/2022
Initial Report FDA Received Date04/25/2022
Supplement Report FDA Received Date07/11/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient SexMale
-
-